Results for tag: "Ventricular Dysfunction Drug"

The Ventricular Dysfunction Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat diseases of the heart and circulatory system. Ventricular Dysfunction Drugs are used to treat conditions such as heart failure, ventricular arrhythmias, and cardiomyopathy. These drugs work by improving the function of the heart muscle, reducing the risk of arrhythmias, and improving the efficiency of the heart's pumping action. Commonly used drugs in this market include ACE inhibitors, beta blockers, diuretics, and anticoagulants. The Ventricular Dysfunction Drug market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in this market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more